Soumit Roy
Stock Analyst at Jones Trading
(0.31)
# 3,049
Out of 4,479 analysts
20
Total ratings
11.11%
Success rate
-20.91%
Average return
Main Sectors:
Top Industries:
15 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INAB IN8bio | Maintains: Buy | $5 → $6.5 | $0.81 | +704.16% | 2 | Jun 14, 2024 | |
| CRVO CervoMed | Initiates: Buy | $70 | $15.85 | +341.64% | 1 | May 29, 2024 | |
| BOLT Bolt Biotherapeutics | Downgrades: Hold | n/a | $0.74 | - | 1 | May 15, 2024 | |
| CGEM Cullinan Oncology | Maintains: Buy | $22 → $26 | $16.31 | +59.41% | 2 | Apr 17, 2024 | |
| JANX Janux Therapeutics | Initiates: Buy | $70 | $39.30 | +78.12% | 1 | Apr 16, 2024 | |
| MNPR Monopar Therapeutics | Upgrades: Buy | $2 | $0.72 | +177.78% | 2 | Apr 11, 2024 | |
| TCON TRACON Pharmaceuticals | Downgrades: Hold | n/a | $0.95 | - | 2 | Aug 21, 2023 | |
| ACRV Acrivon Therapeutics | Initiates: Buy | $26 | $6.08 | +327.63% | 1 | Aug 18, 2023 | |
| ONCY Oncolytics Biotech | Initiates: Buy | $9 | $0.99 | +809.09% | 1 | May 24, 2023 | |
| COEP Coeptis Therapeutics | Initiates: Buy | $4 | $0.28 | +1,354.55% | 1 | Apr 19, 2023 | |
| IKT Inhibikase Therapeutics | Downgrades: Hold | n/a | $1.21 | - | 2 | Nov 16, 2022 | |
| HCWB HCW Biologics | Initiates: Buy | $8 | $0.62 | +1,190.32% | 1 | Nov 8, 2022 | |
| ACET Adicet Bio | Initiates: Buy | n/a | $1.10 | - | 1 | Apr 29, 2021 | |
| SAVA Cassava Sciences | Initiates: Buy | n/a | $11.79 | - | 1 | Mar 17, 2021 | |
| DTIL Precision BioSciences | Initiates: Buy | $810 | $9.41 | +8,507.86% | 1 | Feb 24, 2021 |
IN8bio
Jun 14, 2024
Maintains: Buy
Price Target: $5 → $6.5
Current: $0.81
Upside: +704.16%
CervoMed
May 29, 2024
Initiates: Buy
Price Target: $70
Current: $15.85
Upside: +341.64%
Bolt Biotherapeutics
May 15, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.74
Upside: -
Cullinan Oncology
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $16.31
Upside: +59.41%
Janux Therapeutics
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $39.30
Upside: +78.12%
Monopar Therapeutics
Apr 11, 2024
Upgrades: Buy
Price Target: $2
Current: $0.72
Upside: +177.78%
TRACON Pharmaceuticals
Aug 21, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.95
Upside: -
Acrivon Therapeutics
Aug 18, 2023
Initiates: Buy
Price Target: $26
Current: $6.08
Upside: +327.63%
Oncolytics Biotech
May 24, 2023
Initiates: Buy
Price Target: $9
Current: $0.99
Upside: +809.09%
Coeptis Therapeutics
Apr 19, 2023
Initiates: Buy
Price Target: $4
Current: $0.28
Upside: +1,354.55%
Inhibikase Therapeutics
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.21
Upside: -
HCW Biologics
Nov 8, 2022
Initiates: Buy
Price Target: $8
Current: $0.62
Upside: +1,190.32%
Adicet Bio
Apr 29, 2021
Initiates: Buy
Price Target: n/a
Current: $1.10
Upside: -
Cassava Sciences
Mar 17, 2021
Initiates: Buy
Price Target: n/a
Current: $11.79
Upside: -
Precision BioSciences
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $9.41
Upside: +8,507.86%